The Ever-Expanding Market for Rapid Weight Loss Is a Disaster in the Making
It’s bad enough that drug companies are allowed to market prescription drugs directly to consumers via all sorts of media, but now Eli Lilly is taking it a step further still. The maker of the weight loss drugs Zepbound and Mounjaro has launched a telehealth platform to connect patients with prescribers, thereby making it easier… Read More »